The Avantgarde Crypto Equal Weight fund provides long only exposure to the crypto market via an equally weighted portfolio of tokens, The strategy is designed for investors who want to participate in the broader crypto market but without a large portfolio concentration in any one token. The portfolio allocates to the most liquid tokens within the Ethereum ecosystem and utilizes DeFi protocols to enhance returns on a risk managed basis. The strategy will continue to benefit from enhancements following ongoing research as the opportunity set within the crypto universe continues to evolve.
Key Advantages for Investors
| Key Fund Information | |
| Launch Date | 31 Jul 2023 |
| Fund AuM | $781,835.42 |
| Fund Base Currency | USD |
| Domicile | Bahamas |
| Total Expense Ratio | %1.13 |
| Number of Holdings | 10 |
| Subscriptions | 1 |
| Redemptions | 0 |
| Since Inception | 1 month | 3 months | 6 months | 1 year | 3 years | |
| Avantgarde Fund (USD) | 55.66% | 27.60% | 50.23% | N/A | N/A | N/A |
| Ann. Volatility | N/A% | 59.75% | N/A | N/A | N/A | N/A |
| vs Bitcoin | 7.34% | 17.28% | 5.24% | N/A | N/A | N/A |
| vs Ethereum | 24.96% | 12.90% | 24.86% | N/A | N/A | N/A |
| vs S&P 500 | 56.26% | 12.90% | 24.86% | N/A | N/A | N/A |
| vs Gold | 50.15% | 19.18% | 49.28% | N/A | N/A | N/A |
About Avantgarde
Avantgarde helps institutional investors and crypto-natives get exposure to DeFi investment opportunities. Avantgarde's purpose-built platform provides a unique layer on top of Enzyme to enable the creation of compliant DeFi investment products that can be scaled at low cost.
About Enzyme
Enzyme is an on-chain asset management system that enables access to crypto and DeFi from one simple, unified app. Enzyme enables full automation of reporting, risk management, and operational & administrative requirements via purpose-built smart contracts.
⚠ Disclaimer: https://www.agiodigital.com/legal-disclaimer